Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 301680, 6 pages
http://dx.doi.org/10.5402/2011/301680
Clinical Study

Management of Precancerous Lesions of the Uterine Cervix according to Demographic Data

1Department of Nursing, Centre for Health Services Management and Evaluation, National and Kapodistrian University of Athens, Dilou 1A, Goudi, 115 27 Athens, Greece
2Department of Economics, National and Kapodistrian University of Athens, Pesmazoglou 8, 105 59 Athens, Greece
3Department of Statistics and Actuarial-Financial Mathematics, University of the Aegean, Karlovassi, 83200 Samos Island, Greece

Received 26 September 2010; Accepted 21 October 2010

Academic Editors: J. M. Aldrighi and R. M. Austin

Copyright © 2011 Olga Modinou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Fact sheet No. 297: Cancer,” February 2006, http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
  2. J. Ferlay, F. Bray, P. Pisani, and D. M. Parkin, Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0, IARC Cancer Base 5, IARC, Lyon, France, 2001.
  3. J. D. Goldhaber-Fiebert and S. J. Goldie, “Estimating the cost of cervical cancer screening in five developing countries,” Cost Effectiveness and Resource Allocation, vol. 4, article no. 13, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Hakama, J. Chamberlain, N. E. Day, A. B. Miller, and P. C. Prorok, “Evaluation of screening programmes for gynaecological cancer,” British Journal of Cancer, vol. 52, no. 4, pp. 669–673, 1985. View at Google Scholar
  5. F. X. Bosch, A. Lorincz, N. Muñoz, C. J. L. M. Meijer, and K. V. Shah, “The causal relation between human papillomavirus and cervical cancer,” Journal of Clinical Pathology, vol. 55, no. 4, pp. 244–265, 2002. View at Google Scholar
  6. J. M. M. Walboomers, M. V. Jacobs, and M. V. Jacobs, “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide,” Journal of Pathology, vol. 189, no. 1, pp. 12–19, 1999. View at Publisher · View at Google Scholar
  7. C. Bergeron, “What have we learned and what is still unclear in HPV infections and pre invasive disease?” in Proceedings of the 20th European Congress of Pathology: Update in Pathology, pp. 179–180, European Society of Pathology, 2005.
  8. H. J. Henk, R. P. Insinga, P. K. Singhal, and T. Darkow, “Incidence and costs of cervical intraepithelial neoplasia in a us commercially insured population,” Journal of Lower Genital Tract Disease, vol. 14, no. 1, pp. 29–36, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. X. Castellsagué, V. Rémy, L. M. Puig-Tintoré, R. S. De La Cuesta, N. Gonzalez-Rojas, and C. Cohet, “Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain,” Journal of Lower Genital Tract Disease, vol. 13, no. 1, pp. 38–45, 2009. View at Publisher · View at Google Scholar · View at PubMed
  10. C. Bergeron, J.-G. Breugelmans, S. Bouée, C. Lorans, S. Bénard, and V. Rémy, “Cervical cancer screening andassociated treatment costs in France,” Gynecologie Obstetrique Fertilite, vol. 34, no. 11, pp. 1036–1042, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. P. G. Rossi, A. Ricciardi, and A. Ricciardi, “Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy,” BMC Public Health, vol. 9, article no. 71, 2009. View at Publisher · View at Google Scholar · View at PubMed
  12. C. Kroupis, G. Thomopoulou, T. G. Papathomas, N. Vourlidis, and A. C. Lazaris, “Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece,” Epidemiology and Infection, vol. 135, no. 6, pp. 943–950, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. E. L. Franco, E. Duarte-Franco, and A. Ferenczy, “Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection,” Canadian Medical Association Journal, vol. 164, no. 7, pp. 1017–1025, 2001. View at Google Scholar
  14. C. D. Li, W. Y. Zhang, S. W. Zhang, M. H. Wu, and J. D. Wang, “Analysis of correlation factors for cervical intraepithelial neoplasia in married women in Beijing, China,” Zhonghua yi xue za zhi, vol. 90, no. 3, pp. 196–200, 2010. View at Google Scholar
  15. S. Collins, T. P. Rollason, L. S. Young, and C. B.J. Woodman, “Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study,” European Journal of Cancer, vol. 46, no. 2, pp. 405–411, 2010. View at Publisher · View at Google Scholar · View at PubMed
  16. C. M. Roteli-Martins, K. Panetta, V. A. F. Alves, S. A. C. Siqueira, K. J. Syrjänen, and S. F. M. Derchain, “Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women,” Acta Obstetricia et Gynecologica Scandinavica, vol. 77, no. 6, pp. 678–682, 1998. View at Google Scholar
  17. D. Hellberg, S. Nilsson, N. J. Haley, D. Hoffman, and E. Wynder, “Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers,” American Journal of Obstetrics and Gynecology, vol. 158, no. 4, pp. 910–913, 1988. View at Google Scholar
  18. K. McIntyre-Seltman, P. E. Castle, R. Guido, M. Schiffman, and C. M. Wheeler, “Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1165–1170, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. M. H. Schiffman, N. J. Haley, and J. S. Felton, “Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constituents in the cervix,” Cancer Research, vol. 47, no. 14, pp. 3886–3888, 1987. View at Google Scholar